These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 642116)

  • 21. Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.
    Adjei A; Teuscher NS; Kupper RJ; Chang WW; Greenhill L; Newcorn JH; Connor DF; Wigal S
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):570-8. PubMed ID: 25514542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
    Veronin MA; Nguyen NT
    Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjects.
    Baldoni D; Mackie A; Gutierrez M; Theodor R; Dingemanse J
    Clin Ther; 2013 Nov; 35(11):1842-8. PubMed ID: 24095247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on bioequivalence of domestic bambuterol capsules and imported tablets by high performance capillary zone electrophoresis].
    Shi AX; Li KX; Sun CH; Cao GY
    Yao Xue Xue Bao; 2003 Dec; 38(12):942-5. PubMed ID: 15040091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects.
    Marier JF; Manthos H; Kebir S; Ferron S; DiMarco M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Monif T
    Int J Clin Pharmacol Ther; 2006 May; 44(5):240-6. PubMed ID: 16724579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacokinetic comparison of generic tablets containing bisoprolol with the innovator formulation in healthy volunteers.
    Jovanović D; Cusić S; Rancić D; Srnić D; Perković-Vukcević N
    J Clin Pharmacol; 2006 Oct; 46(10):1217-22. PubMed ID: 16988212
    [No Abstract]   [Full Text] [Related]  

  • 27. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative bio-availability of sultamicillin in healthy volunteers following administration of two tablet formulations.
    Wildfeuer A; Zimmermann T; Eibel G; Lach P; Yeates R; Pfaff G
    J Int Med Res; 1992; 20 Suppl 1():4A-11A. PubMed ID: 1451928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of indomethacin tablets in men volunteers.
    Groth PE; Dunn JM
    Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.
    Sarantopoulos J; Goel S; Chung V; Munster P; Pant S; Patel MR; Infante J; Tawbi H; Becerra C; Bruce J; Kabbinavar F; Lockhart AC; Tan E; Yang S; Carlson G; Scott JW; Sharma S
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):921-927. PubMed ID: 27681579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bioavailability of peroral drug forms of oxacillin].
    Batuashvili TA; Shchedrin VI; Zak AF
    Antibiotiki; 1979 Aug; 24(8):611-5. PubMed ID: 485110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic inequivalence of pharmaceutical alternates.
    Levy RA
    Am Pharm; 1985 Apr; NS25(4):28-39. PubMed ID: 3893084
    [No Abstract]   [Full Text] [Related]  

  • 35. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
    Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
    Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide.
    Blume CD; Williams RL; Upton RA; Lin ET; Benet LZ
    Am J Med; 1984 Nov; 77(5A):59-61. PubMed ID: 6496560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules.
    Nikolova Z; Peng B; Hubert M; Sieberling M; Keller U; Ho YY; Schran H; Capdeville R
    Cancer Chemother Pharmacol; 2004 May; 53(5):433-8. PubMed ID: 15132131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Insight" into drug quality: comparison of simvastatin tablets from the US and Canada obtained via the Internet.
    Veronin MA; Lee E; Lewis EN
    Ann Pharmacother; 2007 Jul; 41(7):1111-5. PubMed ID: 17595307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of tetracycline after different administration forms.
    Altmann AE; Beeuwkes H; Brombacher PJ; Buytendijk HJ; Gijzen AH; Maesen FP
    Clin Chim Acta; 1968 May; 20(2):185-8. PubMed ID: 5655817
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
    Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN
    Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.